BioInvenu is a provider of cell-based assay products and services to drug discovery researchers. It applies its LinkLight technology to G-protein coupled receptors (GPCR), nuclear hormone receptors (NHR), and receptor tyrosine kinases (RTK) by utilizing receptor and its signal adaptor interaction as the functional signal readout. The company enables the identification of biologically relevant compounds that modulate protein-protein interactions.